Overview

Digital PCR (dPCR) and Real-time PCR (qPCR) market is expected to value over USD 4.5 billion with a CAGR of over 8% during the forecast period 2020 to 2027.

The new advances and current research on dPCR and qPCR techniques are spurring market growth. Both the techniques deal with sequencing of DNA or a gene to make millions of  copies. Due to its wide applications in genetics, pharmaceuticals, clinical research, forensic science and so on; the qPCR and dPCR market is growing at a rapid rate across the globe.

Rising risk of genetic disorders, infectious diseases along with awareness, diagnostic centres and hospital requirements serve as one of the major factors responsible for the rapid growth of digital PCR (dPCR) and real-time PCR (qPCR) market. Furthermore, the ease of using the dPCR and qPCR techniques by reducing the number of procedures increases the preference of end users towards accepting these techniques.

The market is segmented into product and service, applications, end users and region. In terms of application, diagnostics, research, biopharmaceuticals,etc. are drivers for market growth. The instruments segment is anticipated to be the dominating factor that contributes to rapid market scale-up.

Clinical and research applications are expected to be drivers for the demand of dPCR and qPCR market. This is because of the inclination of government and non-government bodies towards research in this sector and the funds provided by them and the range of clinical applications like blood screening, oncology testing and diagnosis of other diseases.

North America, Europe and the Asia Pacific regions are anticipated to hold major market shares in dPCR and qPCR market. The increased disease conditions in these regions due to lifestyle habits and increasing population are drivers for market growth in these regions. Furthermore, the demand of dPCR and qPCR research and pharmaceutical advances is more in these regions which support the growth of the market.

Competitive Landscape:

The major players in the market are Abbott Laboratories, Agilent Technologies, Inc, Analytik Gena AG, Becton Dickinson and Company, Biomérieux S.A., Bio-Rad Laboratories, Inc., DanaherCorporation, Hoffman-La Roche Ltd., Fluidigm Corporation, Thermo FisherScientific, Inc.

Abbott Laboratories is estimated to have a large share amongst other competitors. It has a range of advanced dPCR and qPCR products for diagnosis of infectious diseases, oncology testing, genetic testing and so on. 

FutureWise Key Takeaways:

• Research and development in PCR technology and pharmaceuticals
• Focus on new advances in PCR diagnostic instruments
• Commercialization of qPCR and dPCR methods

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:  

By Product and Service:            

• qPCR products and services
  1. qPCR reagents and consumables
  2. qPCR instruments
  3. qPCR software and services
• dPCR products and services
  1.  dPCR reagents and consumables
  2. dPCR instruments
  3. qPCR software and services

By Application:    

• qPCR applications and dPCR applications
  1. Forensic applications
  2. Research applications
  3. Clinical applications
     • Infectious disease testing
     • Oncology testing
     • Blood screening
     • Transplant diagnostics
     • Other applications

By End User:

• dPCR and qPCR end users
  1. Hospitals and diagnostic centres
  2. Research Laboratories and Academic Institutes
  3. Pharmaceutical and Biotechnology companies
  4. Clinical research organizations
  5. Forensic laboratories

By Region:

• North America
• Europe
• Asia pacific
• Latin America
• Middle East and Africa

Objectives of the Study:

• To provide with an exhaustive analysis on the digital PCR (dPCR) and Real-time PCR (qPCR) market by product and service, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

1.3 Study Scope 

        1.3.1 Markets Covered

        1.3.2 Years Considered for the Study

1.4 Currency Used for the Study 

1.5 Market Stakeholders 

2 Research Methodology 

2.1 Research Data 

        2.1.1 Secondary Data

                 2.1.1.1 Key Data From Secondary Sources

        2.1.2 Primary Data

                 2.1.2.1 Key Data From Primary Sources

                 2.1.2.2 Breakdown of Primaries

2.2 Market Estimation Methodology 

        2.2.1 Revenue Mapping-Based Market Estimation

        2.2.2 Usage-Based Market Estimation

        2.2.3 Primary Research Validation

2.3 Data Triangulation 

2.4 Research Assumptions 

2.5 Research Limitations 

3 Executive Summary 

4 Premium Insights 

4.1 Global dPCR and qPCR Market Overview 

4.2 qPCR and dPCR Market, By Region, 2020 Vs.2027 (USD Million) 

4.3 Global qPCR and dPCR Market Share, By Product and Service (2020) 

4.4 Global qPCR Market, By Application, 2020 vs 2027 (USD Million) 

4.5 Geographical Snapshot of dPCR and qPCR Market 

5 Market Overview 

5.1 Introduction 

5.2 Market Dynamics 

        5.2.1 Key Market Drivers

                 5.2.1.1 Rising Incidences of Target Infectious Diseases and Genetic Disorders

                 5.2.1.2 Continuous Technological Advancements in PCR Technologies

                 5.2.1.3 Increasing Investments, Funds, and Grants

                 5.2.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics

                 5.2.1.5 Successful Completion of the Human Genome Project

        5.2.2 Key Market Restraints

                 5.2.2.1 High Device Costs Associated With dPCR

                 5.2.2.2 Technical Limitations of qPCR and dPCR Techniques

        5.2.3 Key Market Opportunities

                 5.2.3.1 Growing Market Penetration in Emerging Countries

                 5.2.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery

        5.2.4 Key Market Challenges

                 5.2.4.1 Adoption and Implementation of Miqe Guidelines

        5.2.5 Key Market Trends

                 5.2.5.1 Development of Compact, Portable, and Lab-On-Chip PCR Devices

                 5.2.5.2 Ongoing Technological Integration With the PCR Process

6 dPCR and qPCR Market, By Product & Service 

6.1 Introduction 

6.2 qPCR Products & Services 

        6.2.1 qPCR Reagents and Consumables

                 6.2.1.1 Global qPCR Reagents and Consumables Market, By Application

                 6.2.1.2 Global qPCR Reagents and Consumables Market, By End User

        6.2.2 qPCR Instruments

                 6.2.2.1 Global qPCR Instruments Market, By Application

                 6.2.2.2 Global qPCR Instruments Market, By End User

        6.2.3 qPCR Software and Services

                 6.2.3.1 Global qPCR Software and Services Market, By Application

                 6.2.3.2 Global qPCR Software and Services Market, By End User

6.3 dPCR Products & Services 

        6.3.1 dPCR Instruments

                 6.3.1.1 Global dPCR Instruments Market, By Application

                 6.3.1.2 Global dPCR Instruments Market, By End User

        6.3.2 dPCR Reagents and Consumables

                 6.3.2.1 Global dPCR Reagents and Consumables Market, By Application

                 6.3.2.2 Global dPCR Reagents and Consumables Market, By End User

        6.3.3 dPCR Software and Services

                 6.3.3.1 Global dPCR Software and Services Market, By Application

                 6.3.3.2 Global dPCR Software and Services Market, By End User

7 dPCR and qPCR Market, By Application 

7.1 Introduction 

7.2 qPCR Applications 

        7.2.1 Clinical Applications

                 7.2.1.1 Infectious Disease Testing

                            7.2.1.1.1 The Wide Availability of qPCR Assays and Kits for Infectious Disease Testing is A Key Factor Driving Market Growth

                 7.2.1.2 Oncology Testing

                            7.2.1.2.1 Advent of Alternative Diagnostic Technologies for Oncology Testing to the Key Restraining Factor

                 7.2.1.3 Blood Screening

                            7.2.1.3.1 The Advantages Offered By qPCR Such as the Elimination of Post-Amplification Processing and Easy Process Automation to Drive the Demand for qPCR Products

                 7.2.1.4 Transplant Diagnostics

                            7.2.1.4.1 Increasing Commercialization of qPCR Products for Transplant Diagnostic to Drive the Market Growth

                 7.2.1.5 Other Clinical Applications

        7.2.2 Research Applications

                 7.2.2.1 Increase in Genome-Based Research Activity Boosts the Market Growth

        7.2.3 Forensic Applications

                 7.2.3.1 Limited Adoption of qPCR in Underdeveloped and Developing Countries is Expected to Restrict the Market Growth

7.3 dPCR Applications 

        7.3.1 Clinical Applications

                 7.3.1.1 Infectious Disease Testing

                            7.3.1.1.1 Accuracy and Precision of dPCR Have Made It A Prominent Tool in Infectious Disease Testing

                 7.3.1.2 Oncology Testing

                            7.3.1.2.1 dPCR Plays A Vital Role in Oncology Testing and Clinical Studies

                 7.3.1.3 Blood Screening

                            7.3.1.3.1 dPCR Offers Multiple Advantages Over Traditional Techniques for Blood Screening

                 7.3.1.4 Transplant Diagnostics

                            7.3.1.4.1 Low Market Availability of dPCR Products for Transplant Diagnostics to Reflect in Small Share of This Market Segment

                 7.3.1.5 Other Clinical Applications

        7.3.2 Research Applications

                 7.3.2.1 Wide Usage of dPCR in Genetic Research is the Primary Driver for Market Growth

        7.3.3 Forensic Applications

                 7.3.3.1 The Need to Reduce the Time and Cost of Forensic Processes is A Key Factor Driving Market Growth

8 dPCR and qPCR Market, By End User 

8.1 Introduction 

8.2 qPCR End Users 

        8.2.1 Hospitals and Diagnostic Centers

        8.2.2 Research Laboratories and Academic Institutes

        8.2.3 Pharmaceutical and Biotechnology Companies

        8.2.4 Clinical Research Organizations

        8.2.5 Forensic Laboratories

8.3 dPCR End Users 

        8.3.1 Hospitals and Diagnostic Centers

        8.3.2 Research Laboratories and Academic Institutes

        8.3.3 Pharmaceutical and Biotechnology Companies

        8.3.4 Clinical Research Organizations

        8.3.5 Forensic Laboratories

9 dPCR and qPCR Market, By Region 

9.1 Introduction 

9.2 North America 

        9.2.1 US

                 9.2.1.1 US to Dominate the North American dPCR and qPCR Market in 2020

        9.2.2 Canada

                 9.2.2.1 Government Initiatives for Supporting Genomics Research to Drive Market Growth in Canada

9.3 Europe 

        9.3.1 Germany

                 9.3.1.1 Germany to Dominate the European dPCR and qPCR Market

        9.3.2 UK

                 9.3.2.1 Growing Focus on Genomics Research to Support Market Growth in the UK

        9.3.3 France

                 9.3.3.1 Initiatives for Developing Genomic Medicine to Support Market Growth in France

        9.3.4 Rest of Europe

9.4 Asia Pacific 

        9.4.1 Japan

                 9.4.1.1 Strong Research and Healthcare Infrastructure to Support Market Growth in Japan

        9.4.2 China

                 9.4.2.1 Healthcare Infrastructure Modernization to Support Market Growth in China

        9.4.3 India

                 9.4.3.1 Presence of A Large Target Patient Population to Support Market Growth in India

        9.4.4 Rest of APAC

9.5 Latin America 

        9.5.1 Brazil

                 9.5.1.1 Brazil Dominated the Latam Market in 2018

        9.5.2 Mexico

                 9.5.2.1 Favorable Trade Agreements Will Support Imports and Improve the Accessibility to dPCR and qPCR Instruments in Mexico

        9.5.3 Rest of Latin America

9.6 Middle East and Africa 

        9.6.1 Low Purchasing Power of End Users and Infrastructural Limitations to Restrain Market Growth in the Mea

10 Competitive Landscape 

  10.1 Overview 

  10.2 Global Market Share Analysis 

          10.2.1 Global qPCR Market Share Analysis (2018)

          10.2.2 Global dPCR Market Share Analysis (2018)

  10.3 Competitive Scenario 

          10.3.1 Key Product Launches, Enhancements, and Approvals (2018–2020)

          10.3.2 Key Partnerships and Collaborations (2018–2020)

          10.3.3 Key Acquisitions (2018–2020)

          10.3.4 Key Expansions (2018–2020)

  10.4 Competitive Leadership Mapping 

          10.4.1 Competitive Leadership Mapping: Major Market Players (2018)

                     10.4.1.1 Visionary Leaders

                     10.4.1.2 Innovators

                     10.4.1.3 Dynamic Differentiators

                     10.4.1.4 Emerging Companies

          10.4.2 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (2018)

                     10.4.2.1 Progressive Companies

                     10.4.2.2 Starting Blocks

                     10.4.2.3 Responsive Companies

                     10.4.2.4 Dynamic Companies

11 Company Profiles 

  11.1 Abbott Laboratories 

          11.1.1 Business Overview

          11.1.2 Products Offered

          11.1.3 Recent Developments .

  11.2 Agilent Technologies, Inc. 

          11.2.1 Business Overview

          11.2.2 Products and Services Offered

          11.2.3 Recent Developments .

  11.3 Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser Ag) 

          11.3.1 Business Overview

          11.3.2 Products and Services Offered

          11.3.3 Recent Developments .

  11.4 Becton Dickinson and Company 

          11.4.1 Business Overview

          11.4.2 Products and Services Offered

          11.4.3 Recent Developments .

  11.5 Biomérieux S.A. 

          11.5.1 Business Overview

          11.5.2 Products and Services Offered

          11.5.3 Recent Developments .

  11.6 Bio-Rad Laboratories, Inc. 

          11.6.1 Business Overview

          11.6.2 Products and Services Offered

          11.6.3 Recent Developments .

          11.6.4 FutureWise View

  11.7 Danaher Corporation 

          11.7.1 Business Overview

          11.7.2 Products Offered

          11.7.3 Recent Developments .

  11.8 Eppendorf AG 

          11.8.1 Business Overview

          11.8.2 Products Offered

          11.8.3 Recent Developments .

  11.9 F. Hoffman-La Roche Ltd. 

          11.9.1 Business Overview

          11.9.2 Products and Services Offered

          11.9.3 Recent Developments .

  11.10 Fluidigm Corporation 

          11.10.1 Business Overview

          11.10.2 Products Offered

          11.10.3 Recent Developments .

  11.11 Merck KGaA 

          11.11.1 Business Overview

          11.11.2 Products and Services Offered

          11.11.3 Recent Developments .

  11.12 Promega Corporation 

          11.12.1 Business Overview

          11.12.2 Products and Services Offered

          11.12.3 Recent Developments .

  11.13 Qiagen N.V. 

          11.13.1 Business Overview

          11.13.2 Products Offered

          11.13.3 Recent Developments .

  11.14 Takara Bio, Inc. 

          11.14.1 Business Overview

          11.14.2 Products and Services Offered

          11.14.3 Recent Developments .

  11.15 Thermo Fisher Scientific, Inc. 

          11.15.1 Business Overview

          11.15.2 Products and Services Offered

          11.15.3 Recent Developments .

          11.15.4 FutureWise Key Takeaways 

12. Research Finding and Conclusion 

13. Appendix 

13.1 Research Methodology 

13.2 Research Data Source 

 

Tables

Figures